The medical marijuana company will soon have operations in half of the state’s designated cannabis patient centers.
Health Care + Med Tech
Construction will begin next year on the facilities that Mayo said are only a fraction of its Destination Medical Center expansion plans.
The clinic was an early investor in the company.
The company has thus far eschewed venture capital.
But annual cost pushed past $25,000 mark for first time, driven largely by prescription drug expenses.
Minneapolis innovation center eyes healthy growth for emerging health care companies.
The company has already begun to make strategic partnerships in the area, specifically to help combat Singapore’s “war on diabetes.”
The organization, composed entirely of women, creates products that help advance the research of complex and deadly diseases.
The exclusive partnership is the first for the well-funded startup.
Following some underwhelming fourth quarter performances by its spine and neuromodulation businesses, the group will take on a “speed to scale initiative.”
The latest and most innovative patents coming out of the Rochester medical powerhouse.
U of M doctors see “new business model” for niche market medications.
But far fewer can use their EHR systems to share patient information with other hospitals.
The med-tech company’s purchase of Covidien last year churned out a massive year-over-year revenue increase of 42 percent.
A look at growth strategies for a dozen Minnesota companies.
The med-tech company now has an upgraded glucose monitoring system and related app in development.
Survey finds private exchanges lag in attracting non-group enrollees for health benefits.
The tissue regeneration company is preparing for human testing.